Synthesis and in vitro antitubercular activity of a series of quinoline derivatives

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A series of 33 quinoline derivatives have been synthesized and evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H(37)Rv using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in microg/mL. Compounds 5e and 5f exhibited a significant activity at 6.25 and 3.12 microg/mL, respectively, when compared with first line drugs such as ethambutol and could be a good starting point to develop new lead compounds in the fight against multi-drug resistant tuberculosis.

Knowledge Graph

Similar Paper

Synthesis and in vitro antitubercular activity of a series of quinoline derivatives
Bioorganic & Medicinal Chemistry 2009.0
Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and anti-mycobacterial activity of (E)-N′-(monosubstituted-benzylidene)isonicotinohydrazide derivatives
European Journal of Medicinal Chemistry 2008.0
New 1,3-oxazolo[4,5-c]quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties
European Journal of Medicinal Chemistry 2010.0
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives
Bioorganic & Medicinal Chemistry 2009.0
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives
European Journal of Medicinal Chemistry 2010.0
New N-arylamino biquinoline derivatives: Synthesis, antimicrobial, antituberculosis, and antimalarial evaluation
European Journal of Medicinal Chemistry 2012.0